» Articles » PMID: 8485623

Inhibition of Spinal Opioid Antinociception by Intrathecal Beta-endorphin1-27 in the Rat

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1993 Apr 1
PMID 8485623
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

1. The effects of intrathecal (i.t.) administration of beta-endorphin and two shorter fragments, human and ovine beta-endorphin1-27, were examined for antinociceptive activity in the tail-flick and paw-pressure tests in the rat. Additionally, the ability of ovine beta-endorphin1-27 to influence the action of i.t. beta-endorphin, morphine and [D-Pen2-D-Pen5]enkephalin (DPDPE) was also examined in these tests. 2. After i.t. injection, beta-endorphin produced potent dose-related antinociception in the tail-flick and paw-pressure tests. Shorter endorphins produced much weaker effects. The order of antinociceptive efficacy was beta-endorphin > human beta-endorphin1-27 > ovine beta-endorphin1-27. 3. Administration of ovine beta-endorphin1-27 (0.72, 1.44 nmol, i.t.) significantly attenuated the antinociceptive effect of beta-endorphin (2.88 nmol, i.t.) in the tail-flick and paw-pressure tests. 4. Both i.t. morphine and DPDPE produced dose-related antinociception in the tail-flick and paw-pressure tests. The potency of DPDPE was lower than that of morphine in both tests; however, the effect of DPDPE was weaker in the paw-pressure test. 5. Administration of ovine beta-endorphin1-27 (1.44 nmol, i.t.) significantly attenuated the antinociceptive effect of morphine (14.9 nmol, i.t.) in both tests and the effect of DPDPE (38.7 nmol) in the tail-flick test. 6. The results show that beta-endorphin1-27 acts as an opioid antagonist at the spinal level in the rat. Its ability to inhibit the action of morphine and DPDPE suggests that it may attenuate beta-endorphin action by an interaction with mu- and/or delta-opioid receptors.

Citing Articles

Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity.

Gong N, Xiao Q, Zhu B, Zhang C, Wang Y, Fan H J Neurosci. 2014; 34(15):5322-34.

PMID: 24719110 PMC: 6608999. DOI: 10.1523/JNEUROSCI.4703-13.2014.


Modulation of morphine antinociception in the mouse by endogenous nitric oxide.

Brignola G, Calignano A, Di Rosa M Br J Pharmacol. 1994; 113(4):1372-6.

PMID: 7889294 PMC: 1510502. DOI: 10.1111/j.1476-5381.1994.tb17149.x.

References
1.
Yaksh T, Rudy T . Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 1976; 17(6):1031-6. DOI: 10.1016/0031-9384(76)90029-9. View

2.
Gianoulakis C, Angelogianni P . Characterization of beta-endorphin peptides in the spinal cord of the rat. Peptides. 1989; 10(5):1049-54. DOI: 10.1016/0196-9781(89)90189-7. View

3.
Wuster M, Schulz R, Herz A . Specificity of opioids towards the mu-, delta- and epsilon-opiate receptors. Neurosci Lett. 1979; 15(2-3):193-8. DOI: 10.1016/0304-3940(79)96112-3. View

4.
Owen J, Milne B, Jhamandas K, Nakatsu K . Assembly of an inexpensive tail flick analgesia meter. J Pharmacol Methods. 1981; 6(1):33-7. DOI: 10.1016/0160-5402(81)90081-4. View

5.
ZAKARIAN S, Smyth D . Distribution of beta-endorphin-related peptides in rat pituitary and brain. Biochem J. 1982; 202(3):561-71. PMC: 1158149. DOI: 10.1042/bj2020561. View